Prof. Bin Wang's team propose a viewpoint on the methods, challenges, and prospects of applying small-sample learning to next-generation human health risk assessment.

Prof. Bin Wang's team evaluated the effect of PM2.5 exposure on very early pregnancy outcomes in women undergoing IVF-ET.

Prof. Bin Wang and Prof. Zhiwen Li's team conducts a series of studies to develop experimental analysis methods for various environmental substances found in human biological samples

Prof. Jufen Liu's team published a paper in Social Science & Medicine revealing effects of hearing impairment of spouse on cognitive health among old married couples

Prof. Jufen Liu's team conducted a series of studies revealing adverse exposures in early life increase the risk of neurodevelopmental and degenerative diseases

Prof. Jufen Liu's team published a paper in eClinicalMedicine revealing multimorbidity patterns increased risks of PD and PD-related functional degeneration among older adults

Prof. Zhiwen Li's team published a paper in Int J Epidemiol revealing periconceptional folic acid supplementation can prevent congenital limb reduction defects

Prof. Bin Wang' team published a paper in The Innovation journal, providing a perspective on the future of exposomics research

Prof. Bin Wang' team published a comprehensive review in the Hygiene & Environmental Health Advances (HEHA) journal on how to apply hair exposomics to construct the relationship between environmental exposure and reproductive health.

Prof. Bin Wang' team conducts a series of environmental health studies based on the analysis of hair samples.

Prof. Bin Wang' team published a paper in Environmental Science & Technology (ES&T) explaining the distribution patterns of trace elements between blood and follicular fluid

Prof. Bin Wang' team published a paper in The Innovation journal explaining the impact of ambient temperature on the transmission rate of COVID-19

Prof. Bin Wang' team published a paper in The Innovation journal explaining the asymptomatic infection rate of COVID-19 in China during the "post-epidemic" period.